If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
200.20    -2.80 (-1.38%)
Bid:
200.20
Ask:
200.40
Spread: 0.20 (0.10%)
Market Cap: £2.04b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Holding(s) in Company

6 Oct 2025 09:15

RNS Number : 1826C
Helios Towers PLC
06 October 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJVQC708

Issuer Name

HELIOS TOWERS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Newlight Partners LP

City of registered office (if applicable)

New York

Country of registered office (if applicable)

United States

4. Details of the shareholder

Name

City of registered office

Country of registered office

Quantum Strategic Partners Ltd.

Cayman Islands

5. Date on which the threshold was crossed or reached

03-Oct-2025

6. Date on which Issuer notified

06-Oct-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

10.900000

0.000000

10.900000

115062729

Position of previous notification (if applicable)

11.570000

0.000000

11.570000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

QB00BJVQC708

115062729

0

10.900000

0.000000

Sub Total 8.A

115062729

10.900000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Ravi Yadav

10.900000

10.900000%

Newlight GP LLC

10.900000

10.900000%

Newlight Partners LP

10.900000

10.900000%

David Wassong

10.900000

10.900000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

06-Oct-2025

13. Place Of Completion

New York, NY

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUPGQCUUPAUMQ
Date   Source Headline
30th Sep 20241:04 pmRNSHolding(s) in Company
16th Sep 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSHalf-year Report
3rd Jul 20247:00 amRNSNotice of H1 2024 Results Date & Conference Call
20th Jun 20246:02 pmRNSHolding(s) in Company
20th Jun 20243:24 pmRNSDirector/PDMR Shareholding
19th Jun 20245:44 pmRNSHolding(s) in Company
19th Jun 20247:00 amRNSRESULTS OF SECONDARY PLACING OF HELIOS TOWERS PLC
18th Jun 20245:05 pmRNSPROPOSED SECONDARY PLACING IN HELIOS TOWERS PLC
31st May 20244:35 pmRNSTender Results Announcement
23rd May 20247:00 amRNSBond Refinancing
20th May 20248:15 amRNSConditional Redemption of Senior Notes
20th May 20248:14 amRNSLaunch of Senior Notes
20th May 20248:14 amRNSOffer to Purchase 2025 Notes
16th May 20247:00 amRNSQ1 2024 Results
10th May 20247:00 amRNSDirectorate Change
3rd May 20247:00 amRNSBlock Listing Six Monthly Return
2nd May 20243:41 pmRNSDirector/PDMR Shareholding
25th Apr 20243:40 pmRNS2024 Annual General Meeting Results
23rd Apr 20247:00 amRNSNotice of Q1 2024 Results Date & Conference Call
22nd Apr 20247:00 amRNSCredit rating upgrade
16th Apr 20242:29 pmRNSDirector/PDMR Shareholding
28th Mar 20248:57 amRNSTotal Voting Rights
25th Mar 202410:31 amRNSDoc re Annual Report and Financial Statements
20th Mar 202412:31 pmRNSDirector/PDMR Shareholding
19th Mar 20242:52 pmRNSHolding(s) in Company
19th Mar 20247:56 amRNSHolding(s) in Company
15th Mar 202412:52 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSResults for the year and quarter ended 31 Dec 2023
26th Jan 20249:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSNotice of FY 2023 Results Date & Conference Call
3rd Nov 20237:05 amRNSBlock Listing Interim Review
2nd Nov 20237:00 amRNSQ3 2023 Results
16th Oct 20237:01 amRNSResults of capped tender offer
16th Oct 20237:00 amRNSResults of Tender Offer for Senior Notes
10th Oct 20237:00 amRNSNotice of Q3 2023 Results Date & Conference Call
3rd Oct 20231:29 pmRNSDirector/PDMR Shareholding
28th Sep 20231:34 pmRNSExtension of Early Tender Time
14th Sep 20237:05 amRNSNew Facilities and tender offer of Senior Notes
14th Sep 20237:00 amRNSUp to $400m Tender Offer for Senior Notes
3rd Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSNotice of H1 2023 Results Date & Conference Call
23rd May 20231:39 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirectorate Change
18th May 20237:00 amRNSQ1 2023 Results
3rd May 202311:25 amRNSBlock Listing Interim Review
27th Apr 20233:39 pmRNS2023 Annual General Meeting Results
17th Apr 20239:44 amRNSNotice of Q1 2023 Results Date & Conference Call
27th Mar 20232:16 pmRNS2022 Annual Report and 2023 Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.